Us Bancorp »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Us Bancorp

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Us Bancorp

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.0k 5.0k 1.41
2025-06-30 $5.7k 5.0k 1.14
2025-03-31 $6.4k 5.0k 1.28
2024-12-31 $5.4k 5.0k 1.08
2024-09-30 $5.9k 5.0k 1.19

More positions owned by Us Bancorp

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Rus Mid Cap Etf (IWR)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)

View all positions for Us Bancorp

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1